In PAD models with diabetes, excessive miR-133a in ischemic muscle or endothelial cells targeted GCH1 and reduced its protein level, which decreases NO synthesis and increases ROS production in the ischemic muscle tissue or endothelial cells. Here, GCH1 is linked to diabetes mellitus.